Related Experiment Videos
Cancer gene therapy using a pro-apoptotic gene, caspase-3
1The First Department of Surgery, Biomedical Research Center, Osaka University Medical School, Suita, Japan.
Gene Therapy
|January 19, 2000
Summary
Human caspase-3 gene therapy shows promise for cancer treatment. Combining caspase-3 gene therapy with etoposide effectively reduced tumor volume, but not in Bcl-2 overexpressing tumors.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Caspase-3, a cysteine protease, is vital for apoptosis.
- Apoptosis is a key process in eliminating cancer cells.
Purpose of the Study:
- To investigate the potential of human caspase-3 gene as an anticancer therapy.
- To evaluate the efficacy of combining caspase-3 gene therapy with etoposide.
Main Methods:
- Gene transduction of human caspase-3 into tumor cells.
- Assessment of apoptosis induction in vitro and in vivo.
- Evaluation in a liver tumor model (AH130) and comparison with Bcl-2 overexpressing tumors.
Main Results:
- Overexpression of caspase-3 alone did not induce significant apoptosis.
- Apoptosis and tumor volume reduction were enhanced by combining caspase-3 gene therapy with etoposide.
- The therapeutic effect was not observed in tumors overexpressing Bcl-2.
Conclusions:
- Caspase-3 gene transduction combined with an additional death stimulus, like etoposide, is a potential anticancer gene therapy strategy.
- This approach is effective in reducing tumor volume but may be limited in Bcl-2 overexpressing tumors.